St. Jude buys Nanostim for $123.5M

St. Jude Medical acquired Nanostim, a developer of miniaturized leadless pacemakers, for $123.5 million after a two-year partnership with the company.

Nanostim’s leadless pacemaker received CE Mark in Europe and conditional approval from the FDA to test the product. The small leadless pacemaker is delivered via a catheter in the femoral vein to the heart. The device is retrievable to replace the battery or reposition it during delivery.

The agreement includes a $65 million cash payment to Milpitas, Calif.-based Nanostim, contingent on meeting defined milestones. St. Jude is based in St. Paul, Minn.

Candace Stuart, Contributor

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Trimed Popup
Trimed Popup